Frontline Testing for Drugs of Abuse

doi:https://doi.org/10.1007/978-1-59259-272-2_11

Open AccessBook Chapter10.1007/978-1-59259-272-2_11

Frontline Testing for Drugs of Abuse

Serge Schneider,Robert Wennig-2002-01-01-Humana Press eBooks

0

TL;DRAbstract

Many non-instrument based immunoassays have been developed and commercialized due their ease of use and rapid results. At least 15 different tests are available, such as the Frontline rapid screen for drugs of abuse. Since the early 1990s Boehringer Mannheim (now Roche Diagnostics) has developed and commercialized these single parameter test strips for qualitative and semiquantitative analysis of cannabinoids, cocaine, opiates, benzodiazepines and amphetamines in urine specimens. The test for methadone is currently under development (1999). The test principle and an evaluation of the different Frontline tests will be presented in this chapter.

Chat with Paper

AI Agents for this Paper

Many non-instrument based immunoassays have been developed and commercialized due their ease of use and rapid results. At least 15 different tests are available, such as the Frontline rapid screen for drugs of abuse. Since the early 1990s Boehringer Mannheim (now Roche Diagnostics) has developed and commercialized these single parameter test strips for qualitative and semiquantitative analysis of cannabinoids, cocaine, opiates, benzodiazepines and amphetamines in urine specimens. The test for methadone is currently under development (1999). The test principle and an evaluation of the different Frontline tests will be presented in this chapter.

Keywords

Drugs of abuseMedicineMethadoneTest (biology)Substance Abuse DetectionSubstance abuseDrugPharmacology

Chat

Click to start Chat